Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro
Por un escritor de hombre misterioso
Descripción
Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
Frontiers Artemisia scoparia and Metabolic Health: Untapped Potential of an Ancient Remedy for Modern Use
Frontiers Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand
Advances in natural product anti-coronavirus research (2002-2022), Chinese Medicine
Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro
Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect
Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 in vitro
Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro
Artemisia annua L. extracts prevent in vitro replication of SARS-CoV-2
Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2
SARS-CoV-2 omicron variants are susceptible in vitro to Artemisia annua hot water extracts - ScienceDirect
IJMS, Free Full-Text
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants
de
por adulto (el precio varía según el tamaño del grupo)